0001415889-22-011632.txt : 20221121
0001415889-22-011632.hdr.sgml : 20221121
20221121163323
ACCESSION NUMBER: 0001415889-22-011632
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20221117
FILED AS OF DATE: 20221121
DATE AS OF CHANGE: 20221121
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: ZELDIS JEROME B
CENTRAL INDEX KEY: 0001433982
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-14778
FILM NUMBER: 221406191
MAIL ADDRESS:
STREET 1: 8767 E. VIA DE VENTURA, SUITE 190
CITY: SCOTTSDALE
STATE: AZ
ZIP: 85258
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: SOLIGENIX, INC.
CENTRAL INDEX KEY: 0000812796
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 411505029
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 29 EMMONS DRIVE
STREET 2: SUITE B-10
CITY: PRINCETON
STATE: NJ
ZIP: 08540
BUSINESS PHONE: 609-538-8200
MAIL ADDRESS:
STREET 1: 29 EMMONS DRIVE
STREET 2: SUITE B-10
CITY: PRINCETON
STATE: NJ
ZIP: 08540
FORMER COMPANY:
FORMER CONFORMED NAME: DOR BIOPHARMA INC
DATE OF NAME CHANGE: 20020329
FORMER COMPANY:
FORMER CONFORMED NAME: ENDOREX CORP
DATE OF NAME CHANGE: 19960916
FORMER COMPANY:
FORMER CONFORMED NAME: IMMUNOTHERAPEUTICS INC
DATE OF NAME CHANGE: 19920703
4
1
form4-11212022_091105.xml
X0306
4
2022-11-17
0000812796
SOLIGENIX, INC.
SNGX
0001433982
ZELDIS JEROME B
C/O SOLIGENIX, INC.
29 EMMONS DRIVE, SUITE B-10
PRINCETON
NJ
08540
true
false
false
false
Stock Option (Right to Buy)
0.65
2022-11-17
4
A
0
46154
0
A
2032-11-16
Common Stock
46154
145285
D
The stock option vests ratably on each of February 17, 2023, May 17, 2023, August 17, 2023 and November 17, 2023.
/s/ Jerome B. Zeldis
2022-11-21